Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insider Analysis From Quintiles On Maximizing Value And Quality In Phase IV Clinical Trials In Asia

This article was originally published in PharmAsia News

Executive Summary

Phase IV trials can translate efficacy to effectiveness and clinical safety to real-world safety, and economic and patient reported outcomes can be assessed for the first time in a more real-world setting. But definitions for Phase IV trials vary across Asia, so companies need to understand the nuances in each setting.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC082898

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel